Search Results - "Bernasconi, E"

Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study by Weber, R, Ruppik, M, Rickenbach, M, Spoerri, A, Furrer, H, Battegay, M, Cavassini, M, Calmy, A, Bernasconi, E, Schmid, P, Flepp, M, Kowalska, J, Ledergerber, B

“…Background Mortality among HIV‐infected persons is decreasing, and causes of death are changing. Classification of deaths is hampered because of low autopsy…”
Get full text

Macrophages promote epithelial repair through hepatocyte growth factor secretion by D'Angelo, F., Bernasconi, E., Schäfer, M., Moyat, M., Michetti, P., Maillard, M. H., Velin, D.

“…Summary Macrophages play a critical role in intestinal wound repair. However, the mechanisms of macrophage‐assisted wound repair remain poorly understood. We…”
Get full text

Outbreak of hepatitis C virus infections originating from a breach in safe injection practices before contrast-enhanced computed tomography scanning by Balmelli, C., Merlani, G., Martinetti, G., Reinholz, D., Paolucci, S., Baldanti, F., Piralla, A., Del Grande, F., Bernasconi, E.

“…Four patients who underwent contrast-enhanced computed tomography (CT) scanning were infected with hepatitis C virus from a contaminated multi-dose vial of…”
Get full text

Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017 by Hampel, B, Kusejko, K, Kouyos, RD, Böni, J, Flepp, M, Stöckle, M, Conen, A, Béguelin, C, Künzler‐Heule, P, Nicca, D, Schmidt, AJ, Nguyen, H, Delaloye, J, Rougemont, M, Bernasconi, E, Rauch, A, Günthard, HF, Braun, DL, Fehr, J, Anagnostopoulos, A., Battegay, M., Bucher, H. C., Calmy, A., Cavassini, M., Ciuffi, A., Dollenmaier, G., Egger, M., Elzi, L., Fellay, J., Furrer, H., Fux, C. A., Haerry, D., Hasse, B., Hirsch, H. H., Hoffmann, M., Hösli, I., Huber, M., Kahlert, C., Kaiser, L., Keiser, O., Klimkait, T., Kovari, H., Ledergerber, B., Martinetti, G., Martinez de Tejada, B., Marzolini, C., Metzner, K. J., Müller, N., Paioni, P., Pantaleo, G., Perreau, M., Rudin, C., Scherrer, A. U., Schmid, P., Speck, R., Tarr, P., Trkola, A., Vernazza, P., Wandeler, G., Weber, R., Yerly, S.

“…Objectives Chemsex refers to the use of sex‐enhancing drugs among men who have sex with men (MSM) in combination with specific sexual and social behaviours…”
Get full text

Changes in Renal Function After Switching From TDF to TAF in HIV-Infected Individuals: A Prospective Cohort Study by Surial, Bernard, Ledergerber, Bruno, Calmy, Alexandra, Cavassini, Matthias, Günthard, Huldrych F, Kovari, Helen, Stöckle, Marcel, Bernasconi, Enos, Schmid, Patrick, Fux, Christoph A, Furrer, Hansjakob, Rauch, Andri, Wandeler, Gilles

“…Abstract Background Replacing tenofovir disoproxil fumarate (TDF) with tenofovir alafenamide (TAF) improves renal tubular markers in HIV-infected individuals…”
Get full text

SARS‐CoV‐2 testing, positivity, and factors associated with COVID‐19 among people with HIV across Europe in the multinational EuroSIDA cohort by Fursa, O., Bannister, W., Neesgaard, B., Podlekareva, D., Kowalska, J., Benfield, T., Gerstoft, J., Reekie, J., Rasmussen, L. D., Aho, I., Guaraldi, G., Staub, T., Miro, J. M., Laporte, J. M., Elbirt, D., Trofimova, T., Sedlacek, D., Matulionyte, R., Oprea, C., Bernasconi, E., Hadžiosmanović, V., Mocroft, A., Peters, L.

“…Background Although people with HIV might be at risk of severe outcomes from infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2;…”
Get full text

Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas by Gaudio, E., Tarantelli, C., Kwee, I., Barassi, C., Bernasconi, E., Rinaldi, A., Ponzoni, M., Cascione, L., Targa, A., Stathis, A., Goodstal, S., Zucca, E., Bertoni, F.

“…Lymphomas are among the most common human cancers and represent the cause of death for still too many patients. The B-cell receptor with its downstream…”
Get full text

Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study by Rosin, C, Elzi, L, Thurnheer, C, Fehr, J, Cavassini, M, Calmy, A, Schmid, P, Bernasconi, E, Battegay, M

“…Objectives Gender‐specific data on the outcome of combination antiretroviral therapy (cART) are a subject of controversy. We aimed to compare treatment…”
Get full text

Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study by HASSE, Barbara, LEDERGERBER, Bruno, FURRER, Hansjakob, BATTEGAY, Manuel, HIRSCHEL, Bernhard, CAVASSINI, Matthias, BERTISCH, Barbara, BERNASCONI, Enos, WEBER, Rainer

Get full text

Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort Study by Kovari, Helen, Calmy, Alexandra, Doco-Lecompte, Thanh, Nkoulou, René, Marzel, Alex, Weber, Rainer, Kaufmann, Philipp A, Buechel, Ronny R, Ledergerber, Bruno, Tarr, Philip E

“…Abstract Background Coronary artery disease (CAD) events have been associated with certain antiretroviral therapy (ART) agents. In contrast, the influence of…”
Get full text

Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo by Pillai, Satish K, Abdel-Mohsen, Mohamed, Guatelli, John, Skasko, Mark, Monto, Alexander, Fujimoto, Katsuya, Yukl, Steven, Greene, Warner C, Kovari, Helen, Rauch, Andri, Fellay, Jacques, Battegay, Manuel, Hirschel, Bernard, Witteck, Andrea, Bernasconi, Enos, Ledergerber, Bruno, Günthard, Huldrych F, Wong, Joseph K

“…The antiviral potency of the cytokine IFN-α has been long appreciated but remains poorly understood. A number of studies have suggested that induction of the…”
Get full text

Participation, retention and uptake in a multicentre pre‐exposure prophylaxis cohort using online, smartphone‐compatible data collection by Hovaguimian, F, Martin, E, Reinacher, M, Rasi, M, Schmidt, AJ, Bernasconi, E, Boffi El Amari, E, Braun, DL, Calmy, A, Darling, K, Christinet, V, Depmeier, C, Hauser, C, Läuchli, S, Notter, J, Stoeckle, M, Surial, B, Vernazza, P, Bruggmann, P, Tarr, P, Haerry, D, Bize, R, Low, N, Lehner, A, Böni, J, Kouyos, RD, Fehr, JS, Hampel, B

“…Objectives The aim of the study was to assess the feasibility of a national pre‐exposure prophylaxis (PrEP) programme using smartphone‐compatible data…”
Get full text

Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study by Ledergerber, Bruno, Furrer, Hansjakob, Rickenbach, Martin, Lehmann, Roger, Elzi, Luigia, Hirschel, Bernard, Cavassini, Matthias, Bernasconi, Enos, Schmid, Patrick, Egger, Matthias, Weber, Rainer

“…Background. Human immunodeficiency virus (HIV)–infected persons may be at increased risk for developing type 2 diabetes mellitus because of viral coinfection…”
Get full text

On the potential of a short‐term intensive intervention to interrupt HCV transmission in HIV‐positive men who have sex with men: A mathematical modelling study by Salazar‐Vizcaya, L., Kouyos, R. D., Fehr, J., Braun, D., Estill, J., Bernasconi, E., Delaloye, J., Stöckle, M., Schmid, P., Rougemont, M., Wandeler, G., Günthard, H. F., Keiser, O., Rauch, A.

“…Summary Increasing access to direct‐acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection and decelerating the rise in high‐risk behaviour…”
Get full text

Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection by Clifford, G M, Lise, M, Franceschi, S, Egger, M, Bouchardy, C, Korol, D, Levi, F, Ess, S, Jundt, G, Wandeler, G, Fehr, J, Schmid, P, Battegay, M, Bernasconi, E, Cavassini, M, Calmy, A, Keiser, O, Schöni-Affolter, F

“…Background: Immunodeficiency and AIDS-related pulmonary infections have been suggested as independent causes of lung cancer among HIV-infected persons, in…”
Get full text

Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV‐infected Individuals by Rotger, M, Tegude, H, Colombo, S, Cavassini, M, Furrer, H, Décosterd, L, Blievernicht, J, Saussele, T, Günthard, H F, Schwab, M, Eichelbaum, M, Telenti, A, Zanger, U M

“…To assess the association of CYP2B6 allelic diversity with efavirenz (EFV) pharmacokinetics, we performed extensive genotyping of 15 relevant single nucleotide…”
Get full text

The novel BTK and PI3K-delta inhibitors acalabrutinib (ACP-196) and ACP-319 show activity in pre-clinical B-cell lymphoma models by Gaudio, E, Tarantelli, C, Spriano, F, Bernasconi, E, Targa, A, Dirnhofer, S, Stathis, A, Zucca, E, Bertoni, F

“…An abstract of the study of Gaudio et. al. about the novel BTK and PI3K-delta inhibitors acalabrutinib (ACP-196) and ACP-319 show activity in pre-clinical…”
Get full text

Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV‐positive people without viral hepatitis in the Swiss HIV Cohort Study by Kovari, H, Surial, B, Tarr, PE, Cavassini, M, Calmy, A, Schmid, P, Bernasconi, E, Rauch, A, Wandeler, G, Ledergerber, B, Aebi‐Popp, K, Anagnostopoulos, A, Battegay, M, Bernasconi, E, Böni, J, Braun, DL, Bucher, HC, Calmy, A, Cavassini, M, Ciuffi, A, Dollenmaier, G, Egger, M, Elzi, L, Fehr, J, Fellay, J, Furrer, H, Fux, CA, Günthard, HF, Haerry, D, Hasse, B, Hirsch, HH, Hoffmann, M, Hösli, I, Huber, M, Kahlert, CR, Kaiser, L, Keiser, O, Klimkait, T, Kouyos, RD, Ledergerber, B, Martinetti, G, Martinez de Tejada, B, Marzolini, C, Metzner, KJ, Müller, N, Nicca, D, Paioni, P, Pantaleo, G, Perreau, M, Rauch, A, Rudin, C, Scherrer, AU, Schmid, P, Speck, R, Stöckle, M, Tarr, P, Trkola, A, Vernazza, P, Wandeler, G, Weber, R, Yerly, S

“…Objectives We previously demonstrated an association between tenofovir disoproxil fumarate (TDF) and chronic liver enzyme elevation in the D:A:D study. The…”
Get full text

Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherence by Courlet, Perrine, Decosterd, Laurent Arthur, Brown, Jennifer Anne, Alves Saldanha, Susana, Marzolini, Catia, Cavassini, Matthias, Stoeckle, Marcel, Csajka, Chantal, Labhardt, Niklaus Daniel, Calmy, Alexandra

Get full text

Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort Study by Boubaker, K., Flepp, M., Sudre, P., Furrer, H., Haensel, A., Hirschel, B., Boggian, K., Chave, J.-P., Bernasconi, E., Egger, M., Opravil, M., Rickenbach, M., Francioli, P., Telenti, A.

“…The prevalence, clinical presentation, and risk factors for hyperlactatemia among patients receiving antiretroviral therapy was determined during a 1-month…”
Get full text